Medicare could have saved over $200 million in payments for definitive drug testing services between 2016 and 2020 if proper program safeguards had been in place, according to a recent audit report by the Office of Inspector General (OIG).Read More »
Over three-quarters of hospitals remain noncompliant with federal price transparency regulations, according to a PatientRightsAdvocate.org report.Read More »
More payers and providers are using the independent dispute resolution (IDR) process than the government anticipated to settle payment for items and services covered by the No Surprises Act.Read More »
